OVERVIEW

Despite the availability of effective medical interventions and therapies for type 2 diabetes, their utilization remains limited. This program aims to increase competency in the treatment of type 2 diabetes and its complications and improve the care of individuals living with type 2 diabetes through four case studies.

LEARNING OBJECTIVES

• Recall when to intensify therapy for people with type 2 diabetes.
• Recognize steps in treatment plans based on guideline-directed therapy to support diverse patient populations in achieving target outcomes.
• Identify treatment options to reduce morbidity and mortality in people with type 2 diabetes. 

• Review the use of glucose-lowering medication for microvascular and macrovascular risk reduction.​​

• Insights into agent-specific considerations as they relate to diabetes’ clinical course among currently available SGLT-2 inhibitors, GLP-1 receptor agonists, dual GIP-GLP-1 receptor agonists, and other medications.​​
• Identify strategies to remove barriers to guideline-directed therapy. ​

CREDITS

2 Free CE (CME, ABIM-MOC, ACPE, ANCC, AAPA, CDR, COP)

EXPIRATION DATE

December 31, 2025

MODULE 1

Optimizing Health Amidst Multiple Comorbidities

This case study addresses the clinical evaluation and management of a 66-year-old male with type 2 diabetes, hypertension and hypercholesterolemia over a 9-month period.

MODULE 2

Maneuvering the Challenges of Obesity and Weight Management

This case study addresses the clinical evaluation and management of a 56-year-old Black male with type 2 diabetes, and referred for assistance with management.

MODULE 3

Navigating Stressors and Social Determinants of Health

This case study addresses the clinical evaluation and management of a 32-year-old female with type 2 diabetes after having untreated gestational diabetes mellitus. 

MODULE 4

Examining the Prevalence of Cardiometabolic Diseases and Conditions

This case study addresses the diagnosis and management of a complex case involving glycemic control, hypertension, dyslipidemia, renal disease, nonalcoholic fatty liver disease and obesity. 

Davida Kruger, NP 
Nurse Practitioner​
Division of Endocrinology​ Henry Ford Health System

Anne Peters, MD
Director, USC Westside Center for Diabetes​ Profession, Keck School of Medicine of USC​
Director, USC Clinical Diabetes Programs

Richard Pratley, MD
Medical Director at the AdventHealth Diabetes Institute, Senior Investigator, Diabetes Program Lead at the Translational Research Institute 

Curtis Triplitt, PharmD, CDE 
Associate Professor/Clinical ​
Department of Medicine​ Division of Diabetes​ UT Health

This activity is supported by an educational grant from Lilly.

Note: You do not need to be an ADA professional member to access our free continuing education programs. Simply create a free account and start exploring 70+ free CE courses. Login to get started!